Cell line · CVCL_0008

Daudi

Cancer cell line, Homo sapiens. EBV-related Burkitt lymphoma. 111 papers.

4 sourcescell-lines-2026-11-14-0.1.0

Cite this record

ConductScience Library. Daudi. Cell lines, record CVCL_0008. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_0008

On this page

Cell line

As Cellosaurus gives it.

Name: Daudi
Accession: CVCL_0008
RRID: RRID:CVCL_0008
Synonyms: DAUDI, NK-10A, NK-10a, NK 10a, NK10a, N, GM03190, GM3190, GM03190A, GM17346
Species: Homo sapiens (Human)
Sex: Male
Age at sampling: 16Y
Category: Cancer cell line
Diseases: EBV-related Burkitt lymphoma (NCIt C27694); Burkitt lymphoma (ORDO Orphanet_543)
Derived from: Peripheral blood (in situ)
Cell type: B-cell
Entry created: 2012-04-04
Entry updated: 2026-06-25

Source Cellosaurus

Problems1

Problem	Cellosaurus's note
Caution	TP53 mutation indicated incorrectly as being at c.637C>T in PubMed=2052620.

Source Cellosaurus

Papers111

Paper	Journal	Year	How we know	Source
APRIL-driven BCMA/TACI dual-targeted ligand-drug conjugates for selective and potent therapy of multiple myeloma.	Acta Pharm Sin B	2026	Its Methods give the RRID and name the line	PubMed
Development of humanized mouse models for the preclinical evaluation of NK cell-based therapies.	Front Immunol	2026	Its Methods give the RRID and name the line	PubMed
A first-in-class bifunctional antibody targeting CD20 and CD37 remodels the immune microenvironment in relapsed or refractory B-cell malignancies.	J Hematol Oncol	2026	Its Methods give the RRID and name the line	PubMed
A Moderate-Affinity Antibody-Drug Conjugate Targeting B7-H3 Exerts Potent Antitumor Efficacy.	Pharmaceuticals (Basel)	2026	Its Methods give the RRID and name the line	PubMed
Zanubrutinib enhances CD19 CAR T killing of B-cell lymphoma by inhibiting BTK phosphorylation, regulating PI3K/AKT/mTOR pathway, and promoting autophagy.	Blood Sci	2026	Its Methods give the RRID and name the line	PubMed
Dual targeting of EZH2 and PD-L1 in Burkitt's lymphoma enhances immune activation and induces apoptotic pathway.	Front Immunol	2025	Its Methods give the RRID and name the line	PubMed
Ammonia Suppresses the Antitumor Activity of Natural Killer Cells and T Cells by Decreasing Mature Perforin.	Cancer Res	2025	Its Methods give the RRID and name the line	PubMed
Maplirpacept: a CD47 decoy receptor with minimal red blood cell binding and robust anti-tumor efficacy.	Front Immunol	2025	Its Methods give the RRID and name the line	PubMed
Phosphorylation-driven epichaperome assembly is a regulator of cellular adaptability and proliferation.	Nat Commun	2024	Its Methods give the RRID and name the line	PubMed
Preclinical Evaluation of STI-8811, a Novel Antibody-Drug Conjugate Targeting BCMA for the Treatment of Multiple Myeloma.	Cancer Res Commun	2024	Its Methods give the RRID and name the line	PubMed

1 to 10 of 111

See all 111 papers

Relatives15

Relation	Cell line	Accession	Source
Derived from it	DIF10	CVCL_UF09	Cell lines
Derived from it	DIF2	CVCL_UF10	Cell lines
Derived from it	DIF3	CVCL_UF11	Cell lines
Derived from it	DIF8	CVCL_UF14	Cell lines
Derived from it	DIF9	CVCL_UF15	Cell lines
Derived from it	DUT	CVCL_ZI16	Cell lines
Derived from it	Daudi-Fluc-EmGFP	CVCL_D5KF	Cell lines
Derived from it	Daudi-Fluc-Puro	CVCL_D5KG	Cell lines
Derived from it	Daudi-Luc2	CVCL_B5KW	Cell lines
Derived from it	Daudi-TG	CVCL_6220	Cell lines

1 to 10 of 15

See all 15 relatives

Cell banks22

Cell bank	Catalog number	Status	Source
ATCC	CCL-213		ATCC
ATCC	CRL-7917	Discontinued	Cellosaurus
AddexBio	C0003010/4669		Cellosaurus
BCRC	60192		BCRC
CCTCC	GDC0097		Cellosaurus
CLS	302009		CLS
Coriell	GM03190		Coriell
Coriell	GM17346		Coriell
DSMZ	ACC-78		DSMZ
ECACC	85011437		ECACC

1 to 10 of 22

See all 22 cell banks

Data dates

The date of each source this release read.

Cellosaurus: 2026-10-22; Cellosaurus
PubMed Central's articles: 2026-11-12; PubMed Central's articles
Our copy of PubMed: 2026-11-06; Our copy of PubMed

Sources 4

CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
PubMedNLM's terms

Each source's terms

CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
PubMedNLM's terms

Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.

For software

Read this cell line from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/cell-lines/v1/CVCL_0008

GET https://conductscience.org/api/cell-lines/v1/CVCL_0008/papers?page=2

API reference For AI assistants